Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH (UROEVAL)

Recordati

Status: Completed

Conditions: Benign Prostatic Hyperplasia

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03179670

KMD 3213-FR-NIS-0019

Details and patient eligibility

About

The high level of unsatisfactory outcome observed in patients treated for LUTS associated with BPH with respect to the different existing therapeutic options strongly emphasizes the need for treatment optimisation in daily practice by a careful LUTS monitoring and treatment adjustment when needed. The poorer outcome observed in patients for whom treatment has been initiated recently suggests that the duration of the disease itself may influence the patient satisfaction.To achieve this goal, we propose to systematically assess LUTS associated with BPH in patients treated for at least 6 months and to assess whether an alpha-blocker therapy initiation/modification may improve the outcome in case of persisting symptoms. We also investigate the influence of the symptom duration on the frequency of unsatisfactory outcome.

Enrollment: 625 patients

Sex: Male

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients aged 60 years or more suffering from LUTS/BPH AND medically treated for at least 6 months.

Exclusion criteria

• Patients with prostate cancer
• Patients requiring surgical treatment
• The absence of Lower Urinary Tract Symptoms
• Treatment initiation for less than 6 months
• Cognitive disorders or other pathologies leading to the inability to give its consent to the collection of data.
• Refusal to participate.